Effects of quercetin on production and release of endothelin and cGMP from cultured endothelial cells

Acta Pharmacologica Sinica

Volumn 17, Issue 5, 1996, Pages 442-444

  Zhao, Xue Ying ^a   Gu, Zhen Lun ^a  

^a Department of Radiation Medicine   (China)

Author keywords

cultured cells; cyclic GMP; endothelins; platelets; quercetin; thrombin; umbilical veins; vascular endothelium

Indexed keywords

CYCLIC GMP; ENDOTHELIN; QUERCETIN; THROMBIN;

ARTICLE; BIOSYNTHESIS; CELL CULTURE; CELL SECRETION; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; RADIOIMMUNOASSAY; THROMBOCYTE; THROMBOCYTE ACTIVATION; UMBILICAL VEIN;

CELLS, CULTURED; CYCLIC GMP; ENDOTHELINS; ENDOTHELIUM, VASCULAR; HUMANS; QUERCETIN; UMBILICAL VEINS;

EID: 0029750215     PISSN: 02539756     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Xiao D, Gu ZL, Qian ZN. Effects of quercetin on platelet and reperfusion-induced arrhythmias in rats. Acta Pharmacol Sin 1993; 14: 505-8.
2. Gu ZL, Qian ZN, Xiao D, Zhou YH, Qin ZH, Wang ZY. Inhibitory effects of quercetin on platelet and its mechanism. Acta Acad Med Suzhou 1991; 11: 262-5.
3. Qin ZH, Shi L. The effects of quercetin on platelet function and membrane lipids. Acta Pharm Sin 1987; 22: 278-80.
4. Gu ZL, Xie ML, Qian ZN. Effect of quercetin on chemilluminescence of human platelets induced by arachidonic acid. Acta Pharmacol Sin 1993; 14: 263-5.
5. Corvazier E, Maclouf J. Interference of some flavonoids and non-steroidal anti-inflammmatory drugs with oxidative metabolism of arachidonic acid by human platelets and neutrophils. Biochim Biophys Acta 1985; 835: 315-21.
6. Ruckstuhl M, Beretz A, Anton R, Landry Y. Flavonoids are selective cyclic GMP phosphodiesterase inhibitors. Biochem Pharmacol 1979; 28: 535-8.
7. He SP, Wei MC, Li RZ, He YQ, Yue BZ, Lu YX. The effect of flavonoids on cyclic nucleotide PDE. J Beijing Med Univ 1982; 14: 253-7.
8. Boulanger C, Luscher TF. Release of endothelin from the porcine aorta: Inhibition by endothelium-derived nitric oxide. J Clin Invest 1990; 85: 587-90.
9. Saito Y, Nakao K, Itoh H, Yamada T, Mukoyama M, Arai H. Endothelin in human plasma and culture medium of aortic endothelial cells-detection and characterization with radioimmunoassay using monoclonal antibody. Biochem Biophys Res Commun 1989; 161: 320-6.
10. Feelisch M, Noack EA. Correlation between nitric oxide formation during degradation of organic nitrates and activation of guanylate cyclase. Eur J Pharmacol 1987; 139: 19-30.
11. Palmer RMJ, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987; 327: 524-6.
12. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev 1991; 43: 109-42.
13. Feigl EO. EDRF - a protective factor? Nature 1988; 331: 490-1.
14. Schini VB, Vanhoutte PM. Endothelin-1: A potent vasoactive peptide. Pharmacol Toxicol 1991; 69: 303-9.